Microglial Immunometabolic Remodeling After Ischemic Stroke: The Interplay Between Mitochondrial Stress and the

Cui Liu1, Qiang Liu1, Weiyao Jing2

  • 1School of Acupuncture and Tuina, Gansu University of Traditional Chine se Medicine, Lanzhou, 730000, China.

Insights

Ischemic stroke alters brain metabolism and microglia function. Understanding these immunometabolic changes and mitochondrial responses is key to developing new stroke therapies.

Area of Science:

  • Neuroscience
  • Immunology
  • Metabolism

Background:

  • Ischemic stroke triggers significant changes in the brain's metabolic and inflammatory environment.
  • These changes impact microglial (brain immune cell) function, leading to immunometabolic remodeling and mitochondrial dysfunction.
  • Current research often focuses on single metabolic pathways, leaving the interplay between the ischemic environment, mitochondrial activity, and microglial responses unclear.

Purpose of the Study:

  • To review and synthesize current evidence on microglial immunometabolism following ischemic stroke.
  • To elucidate the relationships between the ischemic microenvironment, mitochondrial function, and microglial functional states.
  • To identify potential therapeutic targets for stroke by clarifying the metabolic basis of microglial responses.

Main Methods:

  • Literature review of existing studies on microglial metabolism in ischemic stroke.
  • Focus on key metabolic pathways: glycolysis, lactate transport, TCA cycle, succinate signaling, lipid handling, and danger-signal sensing.
  • Emphasis on the connection between these pathways, mitochondrial redox homeostasis, and quality control.

Main Results:

  • Metabolic alterations in stroke vary based on stroke phase, injury severity, and mitochondrial status.
  • Specific metabolic pathways (glycolysis, lipid handling, etc.) critically influence microglial inflammation, debris clearance, and repair.
  • Mitochondrial redox balance and quality control are central to mediating these metabolic effects.

Conclusions:

  • The interplay between the ischemic microenvironment and mitochondrial responses dictates microglial functional outcomes.
  • Clarifying microglial immunometabolism is essential for understanding stroke pathology.
  • This review provides a foundation for developing targeted immunometabolic therapies for stroke.